Vikram Thermo India [VIKRAMTH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Vikram Thermo India
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vikram Thermo India wins in 8 metrics, Sun Pharmaceutical wins in 11 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vikram Thermo India | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 54.85 | 37.88 | Sun Pharmaceutical |
| Price-to-Book Ratio | 3.81 | 5.45 | Vikram Thermo India |
| Debt-to-Equity Ratio | 5.27 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | N/A | -1.94 | N/A |
| EV/EBITDA | 10.60 | 24.14 | Vikram Thermo India |
| Profit Margin (TTM) | 25.77% | 19.29% | Vikram Thermo India |
| Operating Margin (TTM) | 37.09% | 24.34% | Vikram Thermo India |
| EBITDA Margin (TTM) | 37.09% | 24.34% | Vikram Thermo India |
| Return on Equity | 6.67% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | 5.55% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $-159.87M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | 0.47% | 1.26% | Sun Pharmaceutical |
| 1-Year Return | -19.33% | -5.82% | Sun Pharmaceutical |
| Price-to-Sales Ratio (TTM) | 3.74 | 7.32 | Vikram Thermo India |
| Enterprise Value | $4.69B | $3,703.34B | Sun Pharmaceutical |
| EV/Revenue Ratio | 3.79 | 6.89 | Vikram Thermo India |
| Gross Profit Margin (TTM) | 58.07% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $39 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $2.69 | $43.33 | Sun Pharmaceutical |
| Beta (Stock Volatility) | -0.23 | 0.31 | Vikram Thermo India |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vikram Thermo India vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vikram Thermo India | 2.68% | 0.14% | -2.67% | -16.66% | -23.41% | -15.52% |
| Sun Pharmaceutical | -0.53% | 2.69% | -2.45% | -3.91% | -3.48% | -13.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vikram Thermo India | -19.33% | 216.97% | -23.09% | 114.46% | 542.92% | 432.67% |
| Sun Pharmaceutical | -5.82% | 82.10% | 208.33% | 75.01% | 815.76% | 2,735.38% |
Performance & Financial Health Analysis: Vikram Thermo India vs Sun Pharmaceutical
| Metric | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.63B | ₹3.94T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 10,318 | 2,563,431 |
| 90 Day Avg. Volume | 9,094 | 2,041,608 |
| Last Close | ₹151.50 | ₹1,632.70 |
| 52 Week Range | ₹126.85 - ₹216.45 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -30.01% | -16.71% |
| All-Time High | ₹311.00 (Apr 25, 2022) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -51.29% | -16.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.08% | 0.10% |
| Quarterly Earnings Growth | -0.10% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.26% | 0.19% |
| Operating Margin (TTM) | 0.37% | 0.24% |
| Return on Equity (TTM) | 0.07% | 0.15% |
| Debt to Equity (MRQ) | 5.27 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹38.75 | ₹300.99 |
| Cash per Share (MRQ) | ₹0.17 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹324.18M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹80.99M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.47% | 1.26% |
| Last 12-Month Dividend | ₹0.75 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Vikram Thermo India vs Sun Pharmaceutical
| Metric | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 54.85 | 37.88 |
| Forward P/E | N/A | 50.23 |
| PEG Ratio | N/A | -1.94 |
| Price to Sales (TTM) | 3.74 | 7.32 |
| Price to Book (MRQ) | 3.81 | 5.45 |
| Market Capitalization | ||
| Market Capitalization | ₹4.63B | ₹3.94T |
| Enterprise Value | ₹4.69B | ₹3.70T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.79 | 6.89 |
| Enterprise to EBITDA | 10.60 | 24.14 |
| Risk & Other Metrics | ||
| Beta | -0.23 | 0.31 |
| Book Value per Share (MRQ) | ₹38.75 | ₹300.99 |
Financial Statements Comparison: Vikram Thermo India vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹271.07M | ₹137.86B |
| Cost of Goods Sold | ₹113.67M | ₹28.15B |
| Gross Profit | ₹157.40M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹65.96M | ₹33.72B |
| EBITDA | ₹77.14M | ₹47.66B |
| Pre-Tax Income | ₹69.25M | ₹31.73B |
| Income Tax | ₹28.50M | ₹8.70B |
| Net Income (Profit) | ₹40.75M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹1.62M | ₹102.69B |
| Total Current Assets | ₹627.63M | ₹526.24B |
| Total Current Liabilities | ₹200.68M | ₹181.94B |
| Long-Term Debt | ₹21.88M | ₹3.58B |
| Total Shareholders Equity | ₹1.21B | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹449.22M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,318 | 2,563,431 |
| Average Daily Volume (90 Day) | 9,094 | 2,041,608 |
| Shares Outstanding | 31.36M | 2.40B |
| Float Shares | 8.20M | 1.04B |
| % Held by Insiders | 0.69% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Vikram Thermo India vs Sun Pharmaceutical
| Metric | VIKRAMTH | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹0.75 | ₹21.00 |
| Last 12-Month Dividend Yield | 0.47% | 1.26% |
| 3-Year Avg Annual Dividend | ₹0.52 | ₹14.67 |
| 3-Year Avg Dividend Yield | 0.52% | 0.46% |
| 3-Year Total Dividends | ₹1.55 | ₹44.00 |
| Ex-Dividend Date | Sep 23, 2024 | Jul 07, 2025 |